An emerging bacterium, chryseobacterium indologenes a case report and literature review
Abstract
Aerobic, Gram-negative, non-fermenting Chrysobacter endologins are bacilli that are inherently multidrug resistant. Among the infections that have been reported include keratitis, polymyositis, meningitis, pneumonia, and bacteremia in immobilized devices. We describe a rare instance of C. indolognes infection that resulted in bacteremia in a patient receiving intensive care and offer an analysis of cases that are comparable. This report emphasizes the importance of individualized treatment and promotes awareness about this organism as one of many emerging pathogens in immunocompromised adults who are often ICU residents. The most effective agents reported against C. indologes are the quinolones (gatifloxacin and levofloxacin) and trimethoprim-sulfamethoxazole (more than 95% sensitivity). Ciprofloxacin, cefepime, ceftazidime, piperacillin, and rifampin showed significant sensitivity. C. indologenes was obtained from blood cultures. Based on sensitivity, a successful response was observed with piperacillin/tazobactam. Guidelines for this pathogen's management should be taken into consideration given the rise in cases that have been documented in the literature. Levofloxacin, Ciprofloxacin, Piperacillin/Tazobactam, Trimethoprim/Sulfamethoxazole, Piperacillin/Tazobactam, and Rifampin were other effective antimicrobials against C. indologenes.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.